NASDAQ:ICU SeaStar Medical (ICU) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ICU Stock Alerts $0.39 -0.01 (-2.50%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$0.38▼$0.4050-Day Range$0.39▼$1.0152-Week Range$0.16▼$1.72Volume1.19 million shsAverage Volume4.91 million shsMarket Capitalization$29.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get SeaStar Medical alerts: Email Address Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. About SeaStar Medical Stock (NASDAQ:ICU)SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.Read More ICU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICU Stock News HeadlinesMay 6, 2024 | americanbankingnews.comHead-To-Head Survey: SeaStar Medical (ICU) & Its PeersMay 4, 2024 | americanbankingnews.comContrasting SeaStar Medical (ICU) & The CompetitionMay 1, 2024 | msn.comMobility may have dose-response relationship with ICU patient outcomesApril 30, 2024 | globenewswire.comSeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart FailureApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUApril 20, 2024 | finanznachrichten.deSeaStar Medical Holding Corporation: SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUApril 17, 2024 | globenewswire.comSeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateApril 17, 2024 | msn.comSC National Guard conducts medical evacuation drill at Trident Medical CenterApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUApril 11, 2024 | finance.yahoo.comSeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceApril 11, 2024 | globenewswire.comSeaStar Medical to Present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity ConferenceApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUMarch 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUMarch 27, 2024 | globenewswire.comSeaStar Medical to Restate Financials, Sets Business Update Call for April 17March 12, 2024 | globenewswire.comSeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsMarch 11, 2024 | globenewswire.comSeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024February 27, 2024 | finance.yahoo.comManuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureFebruary 27, 2024 | globenewswire.comManuscript Discussing the Benefit of SeaStar Medical's Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureFebruary 23, 2024 | benzinga.comSeaStar Medical Holding Stock (NASDAQ:ICU), Short Interest ReportFebruary 22, 2024 | markets.businessinsider.comSeaStar's Quelimmune Pediatric Device Gets Humanitarian Device Exemption From FDA; Stock DownFebruary 22, 2024 | finance.yahoo.comFDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryFebruary 22, 2024 | finance.yahoo.comNuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™February 22, 2024 | globenewswire.comFDA Grants Humanitarian Device Exemption Approval to SeaStar Medical's Selective Cytopheretic Device for Pediatric Acute Kidney InjuryFebruary 22, 2024 | investorplace.comUnleash Massive Returns With These 3 Top Penny StocksSee More Headlines Receive ICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today5/13/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:ICU CUSIPN/A CIK1831868 Webseastarmedical.com Phone844-427-8100FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,230,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-741.57% Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.18 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.25) per share Price / Book-1.58Miscellaneous Outstanding Shares75,420,000Free Float73,156,000Market Cap$29.71 million OptionableNot Optionable Beta-0.96 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Eric Schlorff (Age 51)CEO, President & Executive Director Comp: $690kDr. H. David Humes M.D.Co-Founder and Managing DirectorColonel Kevin Chung FACP (Age 51)M.D., Chief Medical Officer Comp: $375kMr. David A. Green CPA (Age 61)M.B.A., Chief Financial Officer Tom MullenVice President of Operations & Product DevelopmentKey CompetitorsRetractable TechnologiesNYSE:RVPAkiliNASDAQ:AKLIFemasysNASDAQ:FEMYNeuroOne Medical TechnologiesNASDAQ:NMTCSpectral AINASDAQ:MDAIView All CompetitorsInsidersHeel Kenneth VanBought 100,000 shares on 11/22/2023Total: $40,000.00 ($0.40/share)Kevin ChungBought 12,543 shares on 5/30/2023Total: $5,895.21 ($0.47/share)Richard D RussellBought 20,000 shares on 5/25/2023Total: $10,000.00 ($0.50/share)View All Insider Transactions ICU Stock Analysis - Frequently Asked Questions How have ICU shares performed in 2024? SeaStar Medical's stock was trading at $0.4427 at the start of the year. Since then, ICU stock has decreased by 11.8% and is now trading at $0.3906. View the best growth stocks for 2024 here. When is SeaStar Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our ICU earnings forecast. How were SeaStar Medical's earnings last quarter? SeaStar Medical Holding Co. (NASDAQ:ICU) issued its quarterly earnings data on Tuesday, April, 16th. The company reported ($0.19) earnings per share for the quarter. How do I buy shares of SeaStar Medical? Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ICU) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
